Stereotaxis to acquire Robocath in deal aimed at expanding surgical robotics platform

Beyond beds and buildings: The quiet capital shift reshaping healthcare

The investment case for health technology in India is frequently overstated in one direction and understated in another

Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion

The company allocated €56 million to research and development for next-generation line solutions

Kayentis and RWS partner to improve clinical trial data reliability in CNS studies

Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes

Moberg Pharma reports 2025 annual results, maintains strong cash position

The company reported net revenue of SEK 13.5 million for the full year 2025

Aurobindo’s TheraNym to invest up to $175 million in expanded biologics deal with MSD

TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility

India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs

Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments

Coveris invests €1.8m in Poland to boost speed, capacity & packaging innovation

The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.

India Pharma 2026 concludes with strong call for funding, infrastructure and speed to power innovation

The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions

Pharma firms accelerate regional GLP-1 capacity to de-risk supply chains amid geopolitical tensions: GlobalData

At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy